Pandemic preparedness: At Antimicrobial Regeneration Consortium (ARC) Labs, we are trying to address pandemic preparedness by developing and supporting innovative technologies that can respond to an outbreak in a very short period of time, as well as those that can compete with evolving pathogens. Once the initial scientific breakthrough is made, importantly, the translation of technology (scale-up, pre-clinical data, regulatory approvals etc.) need to occur at an alarming speed, something that is hard to navigate in real-time. Therefore, at ARC we are developing a data-driven network of scientific expertise to provide for a frame-work for translation of technologies.